Compounded GLP-1s arent right for everyone, and your full medical history matters.
Compatibility Notice: For consistency in research environments, you must source and calculate all analytical reagents, solvents, and reconstitution volumes consistently
Highlights: Retatrutide targets GLP-1, GIP, and glucagon to reduce appetite, regulate fat storage, and manage blood sugar A trial showed a higher dose of Retatrutide produced 20% more weight loss over 48 weeks Common side effects include diarrhea, nausea, and vomiting , with at least one death reported Trusted Source Triple-Hormone-Receptor Agonist Retatrutide for Obesity - A Phase 2 Trial Go to source)
However, understanding the medication's side effect profile is important for anyone considering or taking this treatment